Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Rajat Gupta
press@renub.com
www.renub.com/

Bookmark and Share
Adult Vaccines Market & Forecast
Renub Research has announced the addition of the " Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis" report to its offering

BriefingWire.com, 5/14/2014 - Adult Vaccines – Key Facts Covered in the Report

• In the year 2010, GSK was the leader in the adult vaccines landscape.

• In 2012, Merck grabbed the leadership position in the adult vaccines landscape as it provides a wide array of vaccines for various diseases.

• In 2011, Influenza vaccines were the largest segment of the adult vaccine market.

• The Hepatitis vaccines were the second most popular vaccine in the year 2010

• In 2012, the pneumococcal and DTP vaccines garnered double digit share of the adult vaccines market

• The zoster vaccines market is likely to cross a Billion marks by 2020.

• United States comprises the single largest market for adult vaccines market.

Renub Research study titled “Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis” provides a comprehensive assessment of the fast-evolving, high-growth of World Adult Vaccines Landscape. This 222 page report with 142 Figures and 15 Tables studies: 9 Adult Vaccines Market, 5 Companies Adult Vaccines Sales. In total 28 Adult Vaccines have been researched for this report. This report is broadly divided into 11 chapters.

Adult Vaccines Market & Forecast data (2007 – 2020) covered in the report are as follows:

1. Influenza

2. Cervical Cancer/ HPV

3. Hepatitis

4. Zoster Shingles

5. Pneumococcal

6. Measles, Mumps, Rubella and Varicella (MMRV)

7. Meningococcal

8. Diphtheria, Tetanus, Pertussis (DTP)

9. Travel and Miscellaneous

Companies’ Adult Vaccines Sales Share and Forecast data (2007 – 2020) covered in the report

1. GlaxoSmithKline (GSK)

2. Sanofi Pasteur

3. Merck

4. Novartis

5. Pfizer

6. Others

(Chapter 1): Executive Summary

(Chapter 2): This Chapter is divided into 2 parts

A. Adult Vaccines Market and Forecast data from 2007 to 2020

B. Adult Vaccinated Number and Forecast from 2007 to 2020

(Chapter 3): This chapter is divided into 3 parts

A. Provides market share (percentage) of Adult Vaccines in the above mentioned vaccines

B. Provides market share (percentage) of Adult Vaccinated in the above mentioned vaccines

C. Provides above mentioned companies market share in Adult vaccines.

(Chapter No. 4): This chapter is divided into 2 parts

A. Companies given above Sales Share (percentage) in Disease Wise Break up & Forecast

B. Adult Vaccines given above Companies Share and Forecast

(Chapter 5): This chapter talks about all the 9 Adult Vaccines mentioned above. All these vaccines have been further sub-divided into 4 parts

A. Adult Vaccine Market & Forecast

B. Number of Adults Being Vaccinated & Forecast

C. Number of Adult Vaccines Doses & Forecast

D. Number of Cases

(Chapter 6): This chapter studies mentioned above all the 5 companies Adult Vaccines Sales and Forecast. The chapter further talks about the Company alliances with other Companies in order to increase their vaccine sales.

(Chapter 7): This chapter studies mentioned above all the 5 companies’ Sales and Forecast Disease Wise

(Chapter 8): This chapter provides Adult Vaccines Market and Forecast data of 8 Geographic Regions Worldwide.

1. United States

2. North America/Caribbean

3. South America

4. Europe

5. Japan

6. India

7. China

8. Rest of the World (ROW)

(Chapter 9): This chapter comprises of important Mergers and Acquisitions happening in the field of vaccines

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2024 Proserve Technology, Inc.